424B5 filed Nov 2, 2026 at 08:16 ET
Oracle filed a preliminary prospectus supplement for a $10 billion common stock offering, taken down from its November 2, 2026 automatic shelf registration. The offering is concurrent with a $10 billion senior notes offering, though neither is conditioned on the other. Proceeds will be used for general corporate purposes including capital expenditures, debt repayment, acquisitions, or share repurchases. At the $130.67 reference price, the offering represents approximately 2.5% dilution to existing shares outstanding.